Home > Transfer of Technology
Synthesis technology service of cabazitaxel

Synthesis technology service of cabazitaxel
CAS No.: 183133-96-2
English name:cabazitaxel
Cabazitaxel, a second-line drugs for prostate cancer, was developed by Sanofi-aventis Company. It is a semi-synthetic small molecular compound belongs to taxane.
After several years research, we found a very mature synthesis route to get cabazitaxel, with shorter steps and higher yield. 10-DAB as the start material,get the target product after 3 steps.


address: Changping District Of Beijing west tuo village harmonious weiye project base. Tel/Fax:+86-010-84956928 Mobile:+86-13811989488 E-MAIL:han_jsh@hotmail.com Zip code:102206
Copyright © Beijing Harmony Chemical Technology Co., Ltd 2016,All Right Reserved.